Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Get the latest updates from Roche Media News directly as they happen.
Follow now 310 followers
Last updated 4 days ago
4 days ago
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in...
10 days ago
Nearly half of patients on Gazyva/Gazyvaro plus standard therapy achieved a complete...
12 days ago
Susvimo is the first and only continuous delivery treatment that offers an...
16 days ago
As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor...
18 days ago
Basel, 30 January 2025 Group sales grew by 7%1 at constant exchange...
19 days ago
Basel, 29 January 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...
20 days ago
Updated overall survival (OS) results - a key secondary endpoint - reinforce...
21 days ago
Across three key functional outcomes, North Star Ambulatory Assessment (NSAA), Time to...
26 days ago
More than 1 million curable sexually transmitted infections (STIs) are acquired every...
about 1 month ago
Basel, 8 January 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...
about 2 months ago
PADOVA study showed numerical delay in motor progression and positive trends on...
2 months ago
Roche launches its cobas® Mass Spec solution, bringing mass spectrometry to the...